Malignant progression of MES-like cells mediated by COL22A1 in the spatial heterogeneity of glioblastoma
{{output}}
Glioblastoma (GBM), a highly aggressive malignant brain tumor, leads to poor clinical outcomes and low long-term survival rates. Using bioinformatics approaches, we analyzed single-cell RNA sequencing (scRNA-seq) data (GSE273274) from glioma patient samples in... ...
